Enanta Pharma (ENTA) Tops Q1 EPS by 22c
Tweet
Share
E-mailGet Alerts ENTA Hot Sheet
Join SI Premium – FREE
Enanta Pharma (NASDAQ: ENTA) reported Q1 EPS of ($1.05), $0.22 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $16.96 million versus the consensus estimate of $18 million.
For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Incyte settles CMS lawsuit over Opzelura Medicaid rebate rules
- EagleNXT sells five drones to unnamed ASEAN customer
- Vontier names Cameron Richardson group president of Repair Solutions
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
